Muscular Dystrophy Canada Rare Disease Day Update

Rare Disease Day, which occurs on the last day of February (Feb 28th, 2021), is meant to raise awareness amongst the general public and decision-makers about rare diseases and their impact on individuals’ lives. This year, Rare Disease Day will look a little different around the world as we connect virtually instead of in person due to the ongoing COVID-19 pandemic. 

 

Considering many neuromuscular conditions are considered rare, and even ultra-rare, Muscular Dystrophy Canada (MDC) will be featuring individuals with lived experience with varying neuromuscular disorders. 

 

In the week leading up to Rare Disease Day, each day MDC will spotlight a client and their response to the question: how has it been living with a NMD in the midst of the COVID-19 pandemic? These personal stories will showcase the diversified impact of the pandemic on the quality of lives of individuals affected by neuromuscular conditions and reveal individuals’ experiences with interrupted care, increased social isolation/fatigue, frequent cancellation or postponement of treatments and clinic visits, allied health and primary care or specialist appointments, and interrupted rehabilitation and home care supports. 

 

The stories will also highlight the resilience of individuals and their families, the benefits of virtual tele-care and programs for those with mobility challenges and the positive lessons the pandemic has offered. In addition to the personal stories, to increase awareness and knowledge of NMDs, there will be a short plain-language descriptions of the following groups that fall within MDC’s umbrella: 

 

(1)  Muscular Dystrophies 

(2)  Congenital Muscular Dystrophies

(3)  Congenital Myopathies

(4)  Auto-immune Mediated Myopathies

(5)  Metabolic Myopathies

(6)  Genetic and Immune-Mediated Neuromuscular Junction Disorders

(7)  Hereditary Peripheral Nerve Disorders (Genetic Neuropathies)

(8)  Immune-Mediated Peripheral Nerve Disorders

(9)  SMA and related Disorders

 

For more information about Rare Disease Day, please email

 

Return to the February 2021 Newsletter

MDClogo_colour

Read next...

2026 Collaborative Awards Newsletter

Call for Applications: 2026 NMD4C Collaborative Research Training Awards

Application Deadline: June 15, 2026.
We are excited to share that the second cycle of our Collaborative Research Training Award program is now open for applications! 

30th-Research-Grant-Announcement-e1733933500883

Congratulations to our NMD4C Investigators on Receiving a 2025 Defeat Duchenne Canada Research Grant!

NMD4C is proud to celebrate two of our esteemed Investigators, Dr. James Dowling and Dr. Laura McAdam, who have been awarded research grants through the 2026 Defeat Duchenne Canada funding program!

NEWS_ Nomination and Application Deadlines

2026 NMD4C Application & Nomination Deadlines

As we start the new year, three important NMD4C opportunities are approaching their deadlines. Members are invited to nominate a researcher or publication for the Annual NMD4C Awards, apply to join the Basic Science Trainee Committee (BSTC), and apply to attend the 2026 NMD4C Basic Research Summer School, taking place June 8–10 under the leadership of Dr. Mireille Khacho. Registration for the summer school is free, with travel and accommodations covered for non‑local trainees.